GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $304,000 | -33.9% | 3,119 | -16.8% | 0.00% | -50.0% |
| Q2 2020 | $460,000 | -28.2% | 3,748 | -48.8% | 0.00% | -33.3% |
| Q1 2020 | $641,000 | -31.4% | 7,326 | -18.1% | 0.01% | -14.3% |
| Q4 2019 | $935,000 | +50.3% | 8,941 | +65.3% | 0.01% | +40.0% |
| Q3 2019 | $622,000 | -34.2% | 5,409 | -1.3% | 0.01% | -37.5% |
| Q2 2019 | $945,000 | +331.5% | 5,480 | +321.5% | 0.01% | +300.0% |
| Q1 2019 | $219,000 | -88.6% | 1,300 | -91.8% | 0.00% | -60.0% |
| Q1 2017 | $1,927,000 | -17.3% | 15,935 | -23.6% | 0.01% | -28.6% |
| Q4 2016 | $2,330,000 | -22.5% | 20,852 | -8.0% | 0.01% | -22.2% |
| Q3 2016 | $3,007,000 | +38.4% | 22,658 | -4.5% | 0.01% | +28.6% |
| Q2 2016 | $2,172,000 | +320.9% | 23,721 | +231.6% | 0.01% | +250.0% |
| Q1 2016 | $516,000 | – | 7,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |